Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1995 2
1997 1
2010 1
2013 1
2014 3
2015 7
2016 6
2017 6
2018 7
2019 10
2020 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Papi A, Vestbo J, Fabbri L, Corradi M, Prunier H, Cohuet G, Guasconi A, Montagna I, Vezzoli S, Petruzzelli S, Scuri M, Roche N, Singh D. Papi A, et al. Among authors: vezzoli s. Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9. Lancet. 2018. PMID: 29429593 Clinical Trial.
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
Vestbo J, Papi A, Corradi M, Blazhko V, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Singh D. Vestbo J, et al. Among authors: vezzoli s. Lancet. 2017 May 13;389(10082):1919-1929. doi: 10.1016/S0140-6736(17)30188-5. Epub 2017 Apr 3. Lancet. 2017. PMID: 28385353 Clinical Trial.
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
Singh D, Papi A, Corradi M, Pavlišová I, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Vestbo J. Singh D, et al. Among authors: vezzoli s. Lancet. 2016 Sep 3;388(10048):963-73. doi: 10.1016/S0140-6736(16)31354-X. Epub 2016 Sep 1. Lancet. 2016. PMID: 27598678 Clinical Trial.
Efficacy and vitreous levels of topical NSAIDs.
Semeraro F, Russo A, Gambicorti E, Duse S, Morescalchi F, Vezzoli S, Costagliola C. Semeraro F, et al. Among authors: vezzoli s. Expert Opin Drug Deliv. 2015;12(11):1767-82. doi: 10.1517/17425247.2015.1068756. Epub 2015 Jul 14. Expert Opin Drug Deliv. 2015. PMID: 26173446 Review.
Optical Time Reversal from Time-Dependent Epsilon-Near-Zero Media.
Vezzoli S, Bruno V, DeVault C, Roger T, Shalaev VM, Boltasseva A, Ferrera M, Clerici M, Dubietis A, Faccio D. Vezzoli S, et al. Phys Rev Lett. 2018 Jan 26;120(4):043902. doi: 10.1103/PhysRevLett.120.043902. Phys Rev Lett. 2018. PMID: 29437435 Free article.
CdSe/CdS Dot-in-Rods Nanocrystals Fast Blinking Dynamics.
Manceau M, Vezzoli S, Glorieux Q, Giacobino E, Carbone L, De Vittorio M, Hermier JP, Bramati A. Manceau M, et al. Among authors: vezzoli s. Chemphyschem. 2018 Oct 3. doi: 10.1002/cphc.201800694. Online ahead of print. Chemphyschem. 2018. PMID: 30281885
Inhaled corticosteroid containing combinations and mortality in COPD.
Vestbo J, Fabbri L, Papi A, Petruzzelli S, Scuri M, Guasconi A, Vezzoli S, Singh D. Vestbo J, et al. Among authors: vezzoli s. Eur Respir J. 2018 Dec 13;52(6):1801230. doi: 10.1183/13993003.01230-2018. Print 2018 Dec. Eur Respir J. 2018. PMID: 30209195 Free article. No abstract available.
Death after 25C-NBOMe and 25H-NBOMe consumption.
Morini L, Bernini M, Vezzoli S, Restori M, Moretti M, Crenna S, Papa P, Locatelli C, Osculati AMM, Vignali C, Groppi A. Morini L, et al. Among authors: vezzoli s. Forensic Sci Int. 2017 Oct;279:e1-e6. doi: 10.1016/j.forsciint.2017.08.028. Epub 2017 Sep 5. Forensic Sci Int. 2017. PMID: 28893436
Towards spontaneous parametric down conversion from monolayer MoS2.
Dinparasti Saleh H, Vezzoli S, Caspani L, Branny A, Kumar S, Gerardot BD, Faccio D. Dinparasti Saleh H, et al. Among authors: vezzoli s. Sci Rep. 2018 Mar 1;8(1):3862. doi: 10.1038/s41598-018-22270-4. Sci Rep. 2018. PMID: 29497116 Free PMC article.
In vitro antitumor activity of progesterone in human adrenocortical carcinoma.
Fragni M, Fiorentini C, Rossini E, Fisogni S, Vezzoli S, Bonini SA, Dalmiglio C, Grisanti S, Tiberio GAM, Claps M, Cosentini D, Salvi V, Bosisio D, Terzolo M, Missale C, Facchetti F, Memo M, Berruti A, Sigala S. Fragni M, et al. Among authors: vezzoli s. Endocrine. 2019 Mar;63(3):592-601. doi: 10.1007/s12020-018-1795-x. Epub 2018 Oct 26. Endocrine. 2019. PMID: 30367443 Free article.
47 results